Abstract
Current data support that pharmacological modulators of endoplasmic reticulum stress (ERS) have therapeutic potential for diabetic individuals. Therefore, we aimed to examine whether timolol, having free radical-scavenger action, besides being a β-blocker, exerts a cardioprotective effect via inhibition of ERS response in diabetic rats in a comparison with an antioxidant N-acetylcysteine (NAC). Histopathological data showed that either timolol- or NAC-treatment of diabetic rats prevented the changes in mitochondria and nucleus of the cardiac tissue while they enhanced the cellular redox-state in heart as well. The levels of ER-targeted cytoprotective chaperones GRP78 and calnexin, unfolded protein response signaling protein CHO/Gadd153 besides the levels of calpain, BCL-2, phospho-Akt, PUMA, and PML in the hearts from diabetic rats, treated with either timolol or NAC, are found to be similar among these groups, although all these parameters were markedly preserved in the untreated diabetics compared to those of the controls. Taken into consideration how important a balanced-ratio between anti-apoptotic and pro-apoptotic proteins for the maintenance mitochondria/ER function, our results suggest that ERS in diabetic rat heart is mediated by increased oxidative damage, which in turn triggers cardiac dysfunction. Moreover, we also demonstrated that timolol treatment of diabetic rats, similar to NAC treatment, induced a well-controlled redox-state and apoptosis in cardiac myocardium. We, thus for the first time, report that cardioprotective effect of timolol seems to be associated with normalization of ER function due to its antioxidant action in cardiomyocytes even under hyperglycemia.
Similar content being viewed by others
References
Aruoma OI, Smith C, Cecchini R, Evans PJ, Halliwell B (1991) Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism. A physiologically-significant process? Biochem Pharmacol 42(4):735–743
Aydemir-Koksoy A, Bilginoglu A, Sariahmetoglu M, Schulz R, Turan B (2010) Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. J Nutr Biochem 21(9):827–833. doi:10.1016/j.jnutbio.2009.06.006
Boyce M, Yuan J (2006) Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 13(3):363–373. doi:10.1038/sj.cdd.4401817
Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87(10):840–844
Cai L, Kang YJ (2003) Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 3(3):219–228
Cao SS, Kaufman RJ (2013) Targeting endoplasmic reticulum stress in metabolic disease. Expert Opin Ther Targets 17(4):437–448. doi:10.1517/14728222.2013.756471
Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355(9206):773–778. doi:10.1016/S0140-6736(99)08415-9
Carlson SG, Fawcett TW, Bartlett JD, Bernier M, Holbrook NJ (1993) Regulation of the C/EBP-related gene gadd153 by glucose deprivation. Mol Cell Biol 13(8):4736–4744
Castilho RF, Meinicke AR, Almeida AM, Hermes-Lima M, Vercesi AE (1994) Oxidative damage of mitochondria induced by Fe(II)citrate is potentiated by Ca2+ and includes lipid peroxidation and alterations in membrane proteins. Arch Biochem Biophys 308(1):158–163
Ceriello A (2000) Oxidative stress and glycemic regulation. Metabolism 49(2 Suppl 1):27–29
Charles RL, Eaton P (2008) Redox signalling in cardiovascular disease. Proteomics Clin Appl 2(6):823–836. doi:10.1002/prca.200780104
Chen YI, Lee YJ, Wilkie DA, Lin CT (2013a) Evaluation of potential topical and systemic neuroprotective agents for ocular hypertension-induced retinal ischemia-reperfusion injury. Vet Ophthalmol. doi:10.1111/vop.12105
Chen YY, Sun LQ, Wang BA, Zou XM, Mu YM, Lu JM (2013b) Palmitate induces autophagy in pancreatic beta-cells via endoplasmic reticulum stress and its downstream JNK pathway. Int J Mol Med 32(6):1401–1406. doi:10.3892/ijmm.2013.1530
Eichhorn EJ (1992) The paradox of beta-adrenergic blockade for the management of congestive heart failure. Am J Med 92(5):527–538
Eizirik DL, Cardozo AK, Cnop M (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29(1):42–61. doi:10.1210/er.2007-0015
Feuerstein G, Yue TL, Ma X, Ruffolo RR (1998) Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol. Prog Cardiovasc Dis 41(1 Suppl 1):17–24
Fu GS, Huang H, Chen F, Wang HP, Qian LB, Ke XY et al (2007) Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats. Eur J Pharmacol 567(3):223–230. doi:10.1016/j.ejphar.2007.02.036
Gomes A, Costa D, Lima JL, Fernandes E (2006) Antioxidant activity of beta-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species? Bioorg Med Chem 14(13):4568–4577. doi:10.1016/j.bmc.2006.02.023
Goto W, Ota T, Morikawa N, Otori Y, Hara H, Kawazu K et al (2002a) Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina. Brain Res 958(1):10–19
Goto W, Ota T, Morikawa N, Otori Y, Hara H, Kawazu K et al (2002b) Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina. Brain Res 958(1):10–19. doi:10.1016/S0006-8993(02)03372-3
Gray S, Kim JK (2011) New insights into insulin resistance in the diabetic heart. Trends Endocrinol Metab 22(10):394–403. doi:10.1016/j.tem.2011.05.001
Groenendyk J, Agellon LB, Michalak M (2013) Coping with endoplasmic reticulum stress in the cardiovascular system. Annu Rev Physiol 75:49–67. doi:10.1146/annurev-physiol-030212-183707
Guo R, Ma H, Gao F, Zhong L, Ren J (2009) Metallothionein alleviates oxidative stress-induced endoplasmic reticulum stress and myocardial dysfunction. J Mol Cell Cardiol 47(2):228–237. doi:10.1016/j.yjmcc.2009.03.018
Hamada H, Suzuki M, Yuasa S, Mimura N, Shinozuka N, Takada Y et al (2004) Dilated cardiomyopathy caused by aberrant endoplasmic reticulum quality control in mutant KDEL receptor transgenic mice. Mol Cell Biol 24(18):8007–8017. doi:10.1128/MCB.24.18.8007-8017.2004
Izzotti A, Sacca SC, Di Marco B, Penco S, Bassi AM (2008) Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course. Eye (Lond) 22(3):445–453. doi:10.1038/sj.eye.6702737
Kopito RR, Ron D (2000) Conformational disease. Nat Cell Biol 2(11):E207–E209. doi:10.1038/35041139
Kubo H, Margulies KB, Piacentino V 3rd, Gaughan JP, Houser SR (2001) Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 104(9):1012–1018
Lakshmanan AP, Harima M, Suzuki K, Soetikno V, Nagata M, Nakamura T et al (2013) The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of unfolded protein response (UPR) signaling proteins. Int J Biochem Cell Biol 45(2):438–447. doi:10.1016/j.biocel.2012.09.017
Li Z, Zhang T, Dai H, Liu G, Wang H, Sun Y et al (2007) Involvement of endoplasmic reticulum stress in myocardial apoptosis of streptozocin-induced diabetic rats. J Clin Biochem Nutr 41(1):58–67. doi:10.3164/jcbn.2007008
Li J, Xu L, Ye J, Li X, Zhang D, Liang D et al (2013) Aberrant dynamin 2-dependent Na(+)/H(+) exchanger-1 trafficking contributes to cardiomyocyte apoptosis. J Cell Mol Med 17(9):1119–1127. doi:10.1111/jcmm.12086
Luo X, He Q, Huang Y, Sheikh MS (2005) Transcriptional upregulation of PUMA modulates endoplasmic reticulum calcium pool depletion-induced apoptosis via Bax activation. Cell Death Differ 12(10):1310–1318. doi:10.1038/sj.cdd.4401659
Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R et al (2004) CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18(24):3066–3077. doi:10.1101/gad.1250704
Maritim AC, Sanders RA, Watkins JB 3rd (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17(1):24–38. doi:10.1002/jbt.10058
Marra G, Cotroneo P, Pitocco D, Manto A, Di Leo MA, Ruotolo V et al (2002) Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 25(2):370–375
Michalak M, Opas M (2009) Endoplasmic and sarcoplasmic reticulum in the heart. Trends Cell Biol 19(6):253–259. doi:10.1016/j.tcb.2009.03.006
Miyamoto N, Izumi H, Miyamoto R, Kubota T, Tawara A, Sasaguri Y et al (2009) Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress. Invest Ophthalmol Vis Sci 50(6):2777–2784. doi:10.1167/iovs.08-3061
Mochizuki M, Yano M, Oda T, Tateishi H, Kobayashi S, Yamamoto T et al (2007) Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure. J Am Coll Cardiol 49(16):1722–1732. doi:10.1016/j.jacc.2007.01.064
Okatan EN, Tuncay E, Turan B (2013) Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system. J Nutr Biochem 24(12):2110–2118. doi:10.1016/j.jnutbio.2013.08.002
Osborne NN, Wood JP, Chidlow G, Casson R, DeSantis L, Schmidt KG (2004) Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma. Brain Res Bull 62(6):525–528. doi:10.1016/S0361-9230(03)00070-4
Pinton P, Giorgi C, Pandolfi PP (2011) The role of PML in the control of apoptotic cell fate: a new key player at ER-mitochondria sites. Cell Death Differ 18(9):1450–1456. doi:10.1038/cdd.2011.31
Puthalakath H, O’Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND et al (2007) ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129(7):1337–1349. doi:10.1016/j.cell.2007.04.027
Sacca SC, La Maestra S, Micale RT, Larghero P, Travaini G, Baluce B et al (2011) Ability of dorzolamide hydrochloride and timolol maleate to target mitochondria in glaucoma therapy. Arch Ophthalmol 129(1):48–55. doi:10.1001/archophthalmol.2010.324
Sari FR, Watanabe K, Thandavarayan RA, Harima M, Zhang S, Muslin AJ et al (2010) 14-3-3 protein protects against cardiac endoplasmic reticulum stress (ERS) and ERS-initiated apoptosis in experimental diabetes. J Pharmacol Sci 113(4):325–334
Schroder M, Kaufman RJ (2005) ER stress and the unfolded protein response. Mutat Res 569(1–2):29–63. doi:10.1016/j.mrfmmm.2004.06.056
Sgobbo P, Pacelli C, Grattagliano I, Villani G, Cocco T (2007) Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2 -mediated oxidative insult in H9C2 myocardial cells. Biochim Biophys Acta 1767(3):222–232. doi:10.1016/j.bbabio.2007.01.023
Sharma V, Parsons H, Allard MF, McNeill JH (2008) Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3. Eur J Pharmacol 595(1–3):44–51. doi:10.1016/j.ejphar.2008.07.042
Sheikh-Ali M, Sultan S, Alamir AR, Haas MJ, Mooradian AD (2010) Effects of antioxidants on glucose-induced oxidative stress and endoplasmic reticulum stress in endothelial cells. Diabetes Res Clin Pract 87(2):161–166. doi:10.1016/j.diabres.2009.10.023
Shi FH, Cheng YS, Dai DZ, Peng HJ, Cong XD, Dai Y (2013) Depressed calcium-handling proteins due to endoplasmic reticulum stress and apoptosis in the diabetic heart are attenuated by argirein. Naunyn Schmiedebergs Arch Pharmacol 386(6):521–531. doi:10.1007/s00210-013-0852-5
Sozmen NN, Tuncay E, Bilginoglu A, Turan B (2011) Profound cardioprotection with timolol in a female rat model of aging-related altered left ventricular function. Can J Physiol Pharmacol 89(4):277–288. doi:10.1139/Y11-018
Sozzani S, Agwu DE, McCall CE, O’Flaherty JT, Schmitt JD, Kent JD et al (1992) Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C. J Biol Chem 267(28):20481–20488
Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-years cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16(2):434–444
Sun Y, Liu G, Song T, Liu F, Kang W, Zhang Y et al (2008) Upregulation of GRP78 and caspase-12 in diastolic failing heart. Acta Biochim Pol 55(3):511–516
Takada A, Miki T, Kuno A, Kouzu H, Sunaga D, Itoh T et al (2012) Role of ER stress in ventricular contractile dysfunction in type 2 diabetes. PLoS ONE 7(6):e39893. doi:10.1371/journal.pone.0039893
Tang C, Koulajian K, Schuiki I, Zhang L, Desai T, Ivovic A et al (2012) Glucose-induced beta cell dysfunction in vivo in rats: link between oxidative stress and endoplasmic reticulum stress. Diabetologia 55(5):1366–1379. doi:10.1007/s00125-012-2474-8
Thanawala VJ, Forkuo GS, Stallaert W, Leff P, Bouvier M, Bond R (2014) Ligand bias prevents class equality among beta-blockers. Curr Opin Pharmacol 16C:50–57. doi:10.1016/j.coph.2014.03.002
Toblli JE, DiGennaro F, Giani JF, Dominici FP (2012) Nebivolol: impact on cardiac and endothelial function and clinical utility. Vasc Health Risk Manag 8:151–160. doi:10.2147/VHRM.S20669
Toth A, Nickson P, Mandl A, Bannister ML, Toth K, Erhardt P (2007) Endoplasmic reticulum stress as a novel therapeutic target in heart diseases. Cardiovasc Hematol Disord Drug Targets 7(3):205–218
Tuncay E, Zeydanli EN, Turan B (2011) Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca2+ signaling in rat. J Bioenerg Biomembr 43(6):747–756. doi:10.1007/s10863-011-9400-5
Tuncay E, Okatan EN, Vassort G, Turan B (2013) ss-blocker timolol prevents arrhythmogenic Ca(2)(+) release and normalizes Ca(2)(+) and Zn(2)(+) dyshomeostasis in hyperglycemic rat heart. PLoS ONE 8(7):e71014. doi:10.1371/journal.pone.0071014
Wai B, Kearney LG, Hare DL, Ord M, Burrell LM, Srivastava PM (2012) Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control. Cardiovasc Diabetol 11:14. doi:10.1186/1475-2840-11-14
White PJ, Charbonneau A, Cooney GJ, Marette A (2010) Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species. Am J Physiol Endocrinol Metab 299(6):E868–E878. doi:10.1152/ajpendo.00510.2010
Wu T, Dong Z, Geng J, Sun Y, Liu G, Kang W et al (2011) Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats. Eur J Pharm Sci 42(5):496–502. doi:10.1016/j.ejps.2011.02.005
Xu C, Bailly-Maitre B, Reed JC (2005) Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115(10):2656–2664. doi:10.1172/JCI26373
Xu J, Wang G, Wang Y, Liu Q, Xu W, Tan Y et al (2009) Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection. J Cell Mol Med 13(8A):1499–1512. doi:10.1111/j.1582-4934.2009.00833.x
Xu J, Zhou Q, Xu W, Cai L (2012) Endoplasmic reticulum stress and diabetic cardiomyopathy. Exp Diabetes Res 2012:827971. doi:10.1155/2012/827971
Yaras N, Sariahmetoglu M, Bilginoglu A, Aydemir-Koksoy A, Onay-Besikci A, Turan B et al (2008) Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol 155(8):1174–1184. doi:10.1038/bjp.2008.373
Younce CW, Burmeister MA, Ayala JE (2013) Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a. Am J Physiol Cell Physiol 304(6):C508–C518. doi:10.1152/ajpcell.00248.2012
Yu ZK, Chen YN, Aihara M, Mao W, Uchida S, Araie M (2007) Effects of beta-adrenergic receptor antagonists on oxidative stress in purified rat retinal ganglion cells. Mol Vis 13:833–839
Yu X, Cui L, Zhang Z, Zhao Q, Li S (2013) alpha-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis. Acta Biochim Biophys Sin (Shanghai) 45(10):817–826. doi:10.1093/abbs/gmt082
Zhuang XF, Yin CQ, Wang HY, Sun NL (2009) Distinctive effects of carvedilol in the non-infarct zone: remodelling of the ligated rat heart linked to oxidative stress. J Int Med Res 37(5):1354–1364
Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H et al (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12(7):982–995
Acknowledgments
This work has been supported by grant from TUBITAK SBAG-113S466.
Conflict of interest
No conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cicek, F.A., Toy, A., Tuncay, E. et al. Beta-blocker timolol alleviates hyperglycemia-induced cardiac damage via inhibition of endoplasmic reticulum stress. J Bioenerg Biomembr 46, 377–387 (2014). https://doi.org/10.1007/s10863-014-9568-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-014-9568-6